These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 25458357

  • 41. Copper(I) and copper(II) inhibit Aβ peptides proteolysis by insulin-degrading enzyme differently: implications for metallostasis alteration in Alzheimer's disease.
    Grasso G, Pietropaolo A, Spoto G, Pappalardo G, Tundo GR, Ciaccio C, Coletta M, Rizzarelli E.
    Chemistry; 2011 Feb 25; 17(9):2752-62. PubMed ID: 21274957
    [Abstract] [Full Text] [Related]

  • 42. High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor.
    Moy FJ, Chanda PK, Chen JM, Cosmi S, Edris W, Levin JI, Powers R.
    J Mol Biol; 2000 Sep 22; 302(3):671-89. PubMed ID: 10986126
    [Abstract] [Full Text] [Related]

  • 43. Viral capsid assembly as a model for protein aggregation diseases: Active processes catalyzed by cellular assembly machines comprising novel drug targets.
    Marreiros R, Müller-Schiffmann A, Bader V, Selvarajah S, Dey D, Lingappa VR, Korth C.
    Virus Res; 2015 Sep 02; 207():155-64. PubMed ID: 25451064
    [Abstract] [Full Text] [Related]

  • 44. Mechanistic insights into the inhibition of serine proteases by monocyclic lactams.
    Wilmouth RC, Kassamally S, Westwood NJ, Sheppard RJ, Claridge TD, Aplin RT, Wright PA, Pritchard GJ, Schofield CJ.
    Biochemistry; 1999 Jun 22; 38(25):7989-98. PubMed ID: 10387042
    [Abstract] [Full Text] [Related]

  • 45. A dynamic N-capping motif in cytochrome b5: evidence for a pH-controlled conformational switch.
    Davis RB, Lecomte JT.
    Proteins; 2006 May 01; 63(2):336-48. PubMed ID: 16372350
    [Abstract] [Full Text] [Related]

  • 46. Pyrimidine-2,4,6-Triones: a new effective and selective class of matrix metalloproteinase inhibitors.
    Grams F, Brandstetter H, D'Alò S, Geppert D, Krell HW, Leinert H, Livi V, Menta E, Oliva A, Zimmermann G, Gram F, Brandstetter H, D'Alò S, Geppert D, Krell HW, Leinert H, Livi VMenta E, Oliva A, Zimmermann G.
    Biol Chem; 2001 Aug 01; 382(8):1277-85. PubMed ID: 11592410
    [Abstract] [Full Text] [Related]

  • 47. How our bodies fight amyloidosis: effects of physiological factors on pathogenic aggregation of amyloidogenic proteins.
    Huang L, Liu X, Cheng B, Huang K.
    Arch Biochem Biophys; 2015 Feb 15; 568():46-55. PubMed ID: 25615529
    [Abstract] [Full Text] [Related]

  • 48. Functional characterization of the Mycobacterium tuberculosis zinc metallopeptidase Zmp1 and identification of potential substrates.
    Petrera A, Amstutz B, Gioia M, Hähnlein J, Baici A, Selchow P, Ferraris DM, Rizzi M, Sbardella D, Marini S, Coletta M, Sander P.
    Biol Chem; 2012 Jul 15; 393(7):631-40. PubMed ID: 22944667
    [Abstract] [Full Text] [Related]

  • 49. Cyclic peptides bearing a side-chain tail: a tool to model the structure and reactivity of protein zinc sites.
    Sénèque O, Bourlès E, Lebrun V, Bonnet E, Dumy P, Latour JM.
    Angew Chem Int Ed Engl; 2008 Jul 15; 47(36):6888-91. PubMed ID: 18651686
    [No Abstract] [Full Text] [Related]

  • 50. Studying allosteric regulation in metal sensor proteins using computational methods.
    Chakravorty DK, Merz KM.
    Adv Protein Chem Struct Biol; 2014 Jul 15; 96():181-218. PubMed ID: 25443958
    [Abstract] [Full Text] [Related]

  • 51. Calpain inhibition by alpha-ketoamide and cyclic hemiacetal inhibitors revealed by X-ray crystallography.
    Cuerrier D, Moldoveanu T, Inoue J, Davies PL, Campbell RL.
    Biochemistry; 2006 Jun 20; 45(24):7446-52. PubMed ID: 16768440
    [Abstract] [Full Text] [Related]

  • 52. Preface - Matrix metalloproteinases.
    Fridman R.
    Biochim Biophys Acta Mol Cell Res; 2017 Nov 20; 1864(11 Pt A):1925-1926. PubMed ID: 28739264
    [No Abstract] [Full Text] [Related]

  • 53. Editorial: Pathogenic templating proteins in Neurodegenerative Disease.
    Volpicelli-Daley L, Brundin P.
    Neurobiol Dis; 2018 Jan 20; 109(Pt B):175-177. PubMed ID: 29249413
    [No Abstract] [Full Text] [Related]

  • 54. The insulin-degrading enzyme as a link between insulin and neuropeptides metabolism.
    Wacławczyk D, Silberring J, Grasso G.
    J Enzyme Inhib Med Chem; 2021 Dec 20; 36(1):183-187. PubMed ID: 33401948
    [Abstract] [Full Text] [Related]

  • 55. Commentary on Ivancic et al.: Enzyme kinetics from circular dichroism of insulin reveals mechanistic insights into the regulation of insulin-degrading enzyme.
    Grasso G.
    Biosci Rep; 2018 Dec 21; 38(6):. PubMed ID: 30401732
    [Abstract] [Full Text] [Related]

  • 56. Monitoring the biomolecular interactions and the activity of Zn-containing enzymes involved in conformational diseases: experimental methods for therapeutic purposes.
    Grasso G.
    Adv Protein Chem Struct Biol; 2014 Dec 21; 97():115-42. PubMed ID: 25458357
    [Abstract] [Full Text] [Related]

  • 57. THE USE OF MASS SPECTROMETRY TO STUDY ZN-METALLOPROTEASE-SUBSTRATE INTERACTIONS.
    Grasso G.
    Mass Spectrom Rev; 2020 Sep 21; 39(5-6):574-585. PubMed ID: 31898821
    [Abstract] [Full Text] [Related]

  • 58. A new role for old ligands: discerning chelators for zinc metalloproteinases.
    Jacobsen FE, Lewis JA, Cohen SM.
    J Am Chem Soc; 2006 Mar 15; 128(10):3156-7. PubMed ID: 16522091
    [Abstract] [Full Text] [Related]

  • 59. Layers of structure and function in protein aggregation.
    Tanaka M, Komi Y.
    Nat Chem Biol; 2015 Jun 15; 11(6):373-7. PubMed ID: 25978986
    [No Abstract] [Full Text] [Related]

  • 60. In silico study of MMP inhibition.
    Rouffet M, Denhez C, Bourguet E, Bohr F, Guillaume D.
    Org Biomol Chem; 2009 Sep 21; 7(18):3817-25. PubMed ID: 19707688
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.